To offer cross-protection against diverse influenza virus variants, nanoparticle vaccines can produce pivotal cellular and mucosal immune responses that enhance vaccine efficacy and broaden ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback